ID

30372

Beschreibung

https://clinicaltrials.gov/ct2/show/NCT00486954 Study ID: 104578 Clinical Study ID: EGF104578 Study Title: A Randomized, Multicenter, Open-label, Phase III Study of Lapatinib (GW572016) in Combination with weekly Paclitaxel versus weekly Paclitaxel alone in the second line treatment of ErbB2 amplified Advanced Gastric Cancer Patient Level Data: Clinicaltrials.gov Identifier: NCT00486954 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Product Sponsorship Transferred to Novartis Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Gastrointestinal Tract CRF Seiten: 1288-1609

Link

https://clinicaltrials.gov/ct2/show/NCT00486954

Stichworte

Versionen (1)
  1. 30.05.18 30.05.18 - Halim Ugurlu
Rechteinhaber

GlaxoSmithKline (GSK)

Hochgeladen am

30. Mai 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

NCT00486954_Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

Englisch

Study Conclusion, Treatment Confirmation, Pregnancy Information, Death

1 Formulare  
Study Conclusion
Beschreibung

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Date of subject completion or date of subject withdrawal
Beschreibung

Date of subject completion or date of subject withdrawal

Datentyp

date

Alias
UMLS CUI [1,1]
C2983670
UMLS CUI [1,2]
C0422727
UMLS CUI [2]
C0805732
Was the subject withdrawn from the study?
Beschreibung

Was the subject withdrawn from the study?

Datentyp

boolean

Alias
UMLS CUI [1]
C0422727
If yes to withdrawn, plese select primary reason for withdrawal
Beschreibung

If yes to withdrawn

Datentyp

integer

Treatment Confirmation
Beschreibung

Treatment Confirmation

Alias
UMLS CUI-1
C0750484
UMLS CUI-2
C0087111
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Beschreibung

Treatment Confirmation

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0750484
UMLS CUI [1,2]
C0087111
If no, please record reasons
Beschreibung

If no, please record reasons

Datentyp

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C2348235
Pregnancy Information
Beschreibung

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did the subject become pregnant during the study?
Beschreibung

If yes, complete the paper Pregnancy Notification form

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0008976
Did a female partner of the male subject become pregnant during the study?
Beschreibung

If yes, complete the paper Pregnancy Notification form

Datentyp

integer

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0008976
Death
Beschreibung

Death

Alias
UMLS CUI-1
C0011065
Is the subject alive?
Beschreibung

Is the subject alive?

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2584946
UMLS CUI [1,2]
C2348568
If no please enter date of death
Beschreibung

If no please enter date of death

Datentyp

date

Alias
UMLS CUI [1]
C1148348
Primary cause of death
Beschreibung

Primary cause of death

Datentyp

integer

Alias
UMLS CUI [1]
C0007465
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Study Conclusion, Treatment Confirmation, Pregnancy Information, Death

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Date of subject completion or date of subject withdrawal
Item
Date of subject completion or date of subject withdrawal
date
C2983670 (UMLS CUI [1,1])
C0422727 (UMLS CUI [1,2])
C0805732 (UMLS CUI [2])
Was the subject withdrawn from the study?
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
If yes to withdrawn, plese select primary reason for withdrawal
integer
If yes to withdrawn
Code List
If yes to withdrawn, plese select primary reason for withdrawal
CL Item
Adverse evetn, record details on the Non-Serious Adverse Events or Serious Adverse Events forms as appropriate (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor termined study (6)
CL Item
Disease progression (7)
CL Item
Death (25)
CL Item
Invesitagor decision (26)
CL Item
Other, Specify (0)
Item Group
Treatment Confirmation
C0750484 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Treatment Confirmation
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
boolean
C0750484 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
If no, please record reasons
Item
If no, please record reasons
text
C0087111 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Did the subject become pregnant during the study?
Item
Did the subject become pregnant during the study?
boolean
C0032961 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
Item
Did a female partner of the male subject become pregnant during the study?
integer
C0032961 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
undefined item
Code List
Did a female partner of the male subject become pregnant during the study?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (if female partner not of childbearing potential or no female partner) (3)
Item Group
Death
C0011065 (UMLS CUI-1)
Is the subject alive?
Item
Is the subject alive?
boolean
C2584946 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
If no please enter date of death
Item
If no please enter date of death
date
C1148348 (UMLS CUI [1])
Item
Primary cause of death
integer
C0007465 (UMLS CUI [1])
Primary cause of death
Code List
Primary cause of death
CL Item
Disease under study (1)
CL Item
Other, specify (2)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video